NCT04769544

Brief Summary

The functional outcome and longevity of total knee arthroplasty (TKA) is still a concern. Despite various developments in TKA designs, including fixed or mobile bearing, cruciate retaining or posterior stabilized, multi or single radius, it remains unclear which design is superior for achieving a physiological kinematic. In normal healthy knees the medial and lateral tibial condyles are different: the medial is almost flat while the lateral is somewhat convex. Thus, the movement during flexion is asymmetric: during the flexion, the medial condyle is stable throughout the range of motion while the lateral condyle slides anteroposteriorly with respect to femur). Therefore, the native knee requires a specific degree of rollback of the lateral compartment coupled with a medial pivot, which leads to an external axial rotation of the femur. This rollback is thought to be even more pronounced with increasing knee flexion angles to enable deep flexion without excessive shear forces acting at the patella or overloading the extensor mechanism. In addition, stability throughout flexion is a crucial element to normal knee function. Most TKA designs removal of the ACL, and the PCL in posterior-stabilized design, but the TKA do not fully restore the function of those ligaments. Based on this philosophy, the medial pivot TKA was designed to provide better function, patient satisfaction and increased survival. The objective of this study is to analyze whether the medial pivot design provides better outcome and prosthesis survival than conventional total knee arthroplasty.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for not_applicable knee-osteoarthritis

Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 24, 2021

Completed
10 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 7, 2022

Status Verified

April 1, 2022

Enrollment Period

3 years

First QC Date

February 21, 2021

Last Update Submit

April 6, 2022

Conditions

Keywords

knee osteoarthritisTotal knee arthroplastyMedial pivot

Outcome Measures

Primary Outcomes (1)

  • The Knee Society Score

    Functional KSS score (range 0-100) with higher scores as better outcome. A good result is defined as 70 points or greater

    2 years

Study Arms (2)

Medial pivot group

ACTIVE COMPARATOR

Device used: medial pivot total knee arthroplasty design

Device: total knee arthroplasty with medial pivot tibial insert or symmetrical insert

Conventional group

ACTIVE COMPARATOR

Device used: conventional total knee arthroplasty design

Device: total knee arthroplasty with medial pivot tibial insert or symmetrical insert

Interventions

standard surgical implantation of total knee arthroplasty

Conventional groupMedial pivot group

Eligibility Criteria

Age50 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary osteoarthritis of the knee
  • years and older
  • Participants must be able to give informed consent

You may not qualify if:

  • Inflammatory arthritis
  • Traumatic etiology
  • Neurologic disease
  • Neoplastic disease
  • Morbid obesity
  • Severe collateral ligament instability (\> 10° varus/valgus)
  • Severe knee misalignment (greater than 10° of varus or valgus)
  • Flexion contracture greater than 15º
  • Prior surgery on the affected knee (except meniscus)
  • Knee arthroplasty in the contralateral knee

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elda University Hospital

Elda, Alicante, 03600, Spain

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Arthroplasty, Replacement, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Alejandro Lizaur-Utrilla, MD, PhD

    Elda University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alejandro Lizaur-Utrilla, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Double Blind. Patients will be allocated into two groups based on randomized 20-block method by an independent assistant using computer generated randomization. Both patients and evaluators will be blinded with regard to the TKA design.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be treated surgically with a TKA. The two patient groups will include: 1) Study group treated a medial pivot TKA; 2) Control group treated with a conventional TKA. Patients will be followed at regular postoperative intervals by orthopaedic surgeons not involved in the surgeries or cares.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Orthopaedic Surgery Department

Study Record Dates

First Submitted

February 21, 2021

First Posted

February 24, 2021

Study Start

January 1, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

April 7, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
6 months after publication
Access Criteria
Request to the principal investigator

Locations